Liver Resection for Neuroendocrine Tumor Liver Metastases Within Milan Criteria for Liver Transplantation

Andrea Ruzzenente, Fabio Bagante, Francesca Bertuzzo, Luca Aldrighetti, Tommaso Campagnaro, Giorgio Ercolani, Simone Conci, Felice Giuliante, Andrea Dore, Alessandro Ferrero, Guido Torzilli, Gian Luca Grazi, Francesca Ratti, Alessandro Cucchetti, Agostino M. De Rose, Nadia Russolillo, Matteo Cimino, Pasquale Perri, Alfredo Guglielmi, Calogero Iacono

Research output: Contribution to journalArticle

Abstract

Background: The role of liver transplant (LT) for neuroendocrine liver metastasis (NELM) has not been completely defined. While international guidelines included LT as a potential treatment for highly selected patients with advanced NELM, recently, LT has been proposed as an alternative curative treatment for NELM for patients meeting restrictive criteria (Milan criteria). Methods: Using a multi-institutional cohort of patients undergoing liver resection for NELM, the long-term outcomes of patients meeting Milan criteria (resected NET drained by the portal system, stable disease/response to therapies for at least 6 months, metastatic diffusion to < 50% of the total liver volume, a confirmed histology of low-grade, and ≤ 60 years) were investigated. Results: Among the 238 patients included in the study, 28 (12%) patients met the Milan criteria for LT with a 5-year OS of 83%. Furthermore, among patients meeting Milan criteria, subsets of patients with favorable clinic-pathological characteristics had 5-year OS rates greater than 90% including G1 patients (5-year OS, 92%), patients undergoing minor liver resection (5-year OS, 94%), patients with low number of NELM (1–2 NELM), and small tumor size (< 3 cm) (for both groups of patients, 5-year OS, 100%). Conclusions: In our series, only 12% of patients met Milan criteria, and the 5-year OS after liver resection for this small selected group of patients was comparable with that reported in the literature for patients undergoing LT for NELM within Milan criteria. While LT might be the optimal treatment for patients with unresectable NELM, surgical resection should be the first option for patients with resectable NELM.

Original languageEnglish
Pages (from-to)93-100
Number of pages8
JournalJournal of Gastrointestinal Surgery
Volume23
Issue number1
DOIs
Publication statusPublished - Jan 15 2018

Keywords

  • Liver surgery
  • Liver transplant
  • Neuroendocrine liver metastasis

ASJC Scopus subject areas

  • Surgery
  • Gastroenterology

Fingerprint Dive into the research topics of 'Liver Resection for Neuroendocrine Tumor Liver Metastases Within Milan Criteria for Liver Transplantation'. Together they form a unique fingerprint.

  • Cite this

    Ruzzenente, A., Bagante, F., Bertuzzo, F., Aldrighetti, L., Campagnaro, T., Ercolani, G., Conci, S., Giuliante, F., Dore, A., Ferrero, A., Torzilli, G., Grazi, G. L., Ratti, F., Cucchetti, A., De Rose, A. M., Russolillo, N., Cimino, M., Perri, P., Guglielmi, A., & Iacono, C. (2018). Liver Resection for Neuroendocrine Tumor Liver Metastases Within Milan Criteria for Liver Transplantation. Journal of Gastrointestinal Surgery, 23(1), 93-100. https://doi.org/10.1007/s11605-018-3973-9